Anthony Petrone
Stock Analyst at Mizuho
(3.86)
# 788
Out of 4,479 analysts
133
Total ratings
54.05%
Success rate
6.58%
Average return
Main Sectors:
26 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADMA ADMA Biologics | Maintains: Buy | $12 → $14 | $11.40 | +22.81% | 6 | Jun 20, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $65 → $70 | $42.75 | +63.74% | 6 | Jun 6, 2024 | |
| ALC Alcon | Maintains: Buy | $100 → $105 | $88.79 | +18.26% | 7 | May 15, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $85 → $90 | $76.55 | +17.57% | 6 | May 15, 2024 | |
| STAA STAAR Surgical Company | Maintains: Buy | $53 → $55 | $44.52 | +23.54% | 7 | May 8, 2024 | |
| LNTH Lantheus Holdings | Maintains: Buy | $90 → $100 | $78.50 | +27.39% | 5 | May 3, 2024 | |
| LIVN LivaNova | Maintains: Buy | $75 → $80 | $52.89 | +51.26% | 6 | May 2, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $110 → $105 | $76.33 | +37.56% | 6 | May 1, 2024 | |
| NVRO Nevro | Maintains: Neutral | $20 → $16 | $8.35 | +91.62% | 3 | Apr 11, 2024 | |
| GKOS Glaukos | Maintains: Neutral | $85 → $100 | $118.98 | -15.95% | 5 | Apr 11, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $95 → $105 | $91.23 | +15.09% | 7 | Apr 11, 2024 | |
| RMD ResMed | Maintains: Buy | $215 | $189.35 | +13.55% | 8 | Mar 27, 2024 | |
| INSP Inspire Medical Systems | Maintains: Buy | $250 | $134.25 | +86.22% | 6 | Mar 27, 2024 | |
| TARS Tarsus Pharmaceuticals | Maintains: Buy | $30 → $44 | $27.55 | +59.71% | 1 | Mar 6, 2024 | |
| MDXG MiMedx Group | Maintains: Buy | $13 → $14 | $6.78 | +106.49% | 4 | Mar 1, 2024 | |
| COO The Cooper Companies | Maintains: Buy | $103 → $115 | $86.51 | +32.93% | 13 | Mar 1, 2024 | |
| MDT Medtronic | Maintains: Buy | $95 → $98 | $77.37 | +26.66% | 4 | Feb 21, 2024 | |
| ISRG Intuitive Surgical | Maintains: Neutral | $350 → $390 | $438.81 | -11.12% | 6 | Jan 25, 2024 | |
| TFX Teleflex | Maintains: Neutral | $225 → $235 | $211.25 | +11.24% | 6 | Nov 3, 2023 | |
| LMAT LeMaitre Vascular | Downgrades: Hold | $63 → $67 | $81.19 | -17.48% | 2 | Aug 3, 2023 | |
| ABT Abbott Laboratories | Assumes: Neutral | $110 → $115 | $103.20 | +11.43% | 3 | Jul 21, 2023 | |
| AXNX Axonics | Reiterates: Buy | $75 | $67.45 | +11.19% | 2 | Jul 14, 2023 | |
| HOLX Hologic | Reiterates: Buy | $95 | $73.53 | +29.20% | 6 | Jun 15, 2023 | |
| HAE Haemonetics | Maintains: Buy | $110 → $115 | $83.06 | +38.45% | 6 | Feb 8, 2023 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | n/a | $106.27 | - | 1 | Nov 5, 2021 | |
| VREX Varex Imaging | Downgrades: Hold | n/a | $14.58 | - | 1 | Feb 12, 2020 |
ADMA Biologics
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $11.40
Upside: +22.81%
Establishment Labs Holdings
Jun 6, 2024
Maintains: Buy
Price Target: $65 → $70
Current: $42.75
Upside: +63.74%
Alcon
May 15, 2024
Maintains: Buy
Price Target: $100 → $105
Current: $88.79
Upside: +18.26%
Boston Scientific
May 15, 2024
Maintains: Buy
Price Target: $85 → $90
Current: $76.55
Upside: +17.57%
STAAR Surgical Company
May 8, 2024
Maintains: Buy
Price Target: $53 → $55
Current: $44.52
Upside: +23.54%
Lantheus Holdings
May 3, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $78.50
Upside: +27.39%
LivaNova
May 2, 2024
Maintains: Buy
Price Target: $75 → $80
Current: $52.89
Upside: +51.26%
GE HealthCare Technologies
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $76.33
Upside: +37.56%
Nevro
Apr 11, 2024
Maintains: Neutral
Price Target: $20 → $16
Current: $8.35
Upside: +91.62%
Glaukos
Apr 11, 2024
Maintains: Neutral
Price Target: $85 → $100
Current: $118.98
Upside: -15.95%
Edwards Lifesciences
Apr 11, 2024
Maintains: Buy
Price Target: $95 → $105
Current: $91.23
Upside: +15.09%
ResMed
Mar 27, 2024
Maintains: Buy
Price Target: $215
Current: $189.35
Upside: +13.55%
Inspire Medical Systems
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $134.25
Upside: +86.22%
Tarsus Pharmaceuticals
Mar 6, 2024
Maintains: Buy
Price Target: $30 → $44
Current: $27.55
Upside: +59.71%
MiMedx Group
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $6.78
Upside: +106.49%
The Cooper Companies
Mar 1, 2024
Maintains: Buy
Price Target: $103 → $115
Current: $86.51
Upside: +32.93%
Medtronic
Feb 21, 2024
Maintains: Buy
Price Target: $95 → $98
Current: $77.37
Upside: +26.66%
Intuitive Surgical
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $438.81
Upside: -11.12%
Teleflex
Nov 3, 2023
Maintains: Neutral
Price Target: $225 → $235
Current: $211.25
Upside: +11.24%
LeMaitre Vascular
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $81.19
Upside: -17.48%
Abbott Laboratories
Jul 21, 2023
Assumes: Neutral
Price Target: $110 → $115
Current: $103.20
Upside: +11.43%
Axonics
Jul 14, 2023
Reiterates: Buy
Price Target: $75
Current: $67.45
Upside: +11.19%
Hologic
Jun 15, 2023
Reiterates: Buy
Price Target: $95
Current: $73.53
Upside: +29.20%
Haemonetics
Feb 8, 2023
Maintains: Buy
Price Target: $110 → $115
Current: $83.06
Upside: +38.45%
Zimmer Biomet Holdings
Nov 5, 2021
Maintains: Buy
Price Target: n/a
Current: $106.27
Upside: -
Varex Imaging
Feb 12, 2020
Downgrades: Hold
Price Target: n/a
Current: $14.58
Upside: -